Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_assertion description "[2-phenylimidazo[2,1-b]benzothiazole derivatives have been highlighted for their properties of targeting oncogenic Met receptor tyrosine kinase (RTK) signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_assertion evidence source_evidence_literature NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_assertion SIO_000772 23071625 NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_assertion wasDerivedFrom befree-2016 NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_assertion wasGeneratedBy ECO_0000203 NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.
- befree-2016 importedOn "2016-02-19" NP1021533.RAz1kNEpdWtNk47BHMU22aZyt7ZhvZJfu6NM89ReByS30130_provenance.